Cargando…
Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm
BACKGROUND: Daptomycin is increasingly used in the treatment of bone and joint infections (BJIs) and may be responsible for daptomycin-induced eosinophilic pneumonia (DIEP), a potentially severe adverse drug reaction. The aim of this study was to describe DIEP in patients treated at a referral cente...
Autores principales: | Pham, Truong-Thanh, Garreau, Romain, Craighero, Fabien, Cottin, Vincent, Said, Benoît Ben, Goutelle, Sylvain, Ferry, Tristan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697587/ https://www.ncbi.nlm.nih.gov/pubmed/36447615 http://dx.doi.org/10.1093/ofid/ofac577 |
Ejemplares similares
-
Implementation and Comparison of Two Pharmacometric Tools for Model-Based Therapeutic Drug Monitoring and Precision Dosing of Daptomycin
por: Heitzmann, Justine, et al.
Publicado: (2022) -
Eosinophilic Syndromes Associated With Daptomycin Use: Re-exposure Hypersensitivity Pneumonitis and Prior Peripheral Eosinophilia
por: West, Katelyn A, et al.
Publicado: (2022) -
Population Pharmacokinetics and Dosing Simulation of Vancomycin Administered by Continuous Injection in Critically Ill Patient
por: Garreau, Romain, et al.
Publicado: (2021) -
Daptomycin-Resistant Enterococcus Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation
por: Lee, Rachael A, et al.
Publicado: (2022) -
Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study
por: Ferry, Tristan, et al.
Publicado: (2021)